[go: up one dir, main page]

ZA200604616B - Inhalable tiotropium and container therefor - Google Patents

Inhalable tiotropium and container therefor

Info

Publication number
ZA200604616B
ZA200604616B ZA200604616A ZA200604616A ZA200604616B ZA 200604616 B ZA200604616 B ZA 200604616B ZA 200604616 A ZA200604616 A ZA 200604616A ZA 200604616 A ZA200604616 A ZA 200604616A ZA 200604616 B ZA200604616 B ZA 200604616B
Authority
ZA
South Africa
Prior art keywords
dose
tiotropium
moisture
container
sealed
Prior art date
Application number
ZA200604616A
Other languages
English (en)
Inventor
Nilsson Thomas
Myrman Mattias
Calander Sven
Niemi Alf
Original Assignee
Beehringer Ingelhem Internat G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29778162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200604616(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beehringer Ingelhem Internat G filed Critical Beehringer Ingelhem Internat G
Publication of ZA200604616B publication Critical patent/ZA200604616B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Table Devices Or Equipment (AREA)
  • Containers Having Bodies Formed In One Piece (AREA)
ZA200604616A 2003-12-03 2004-12-02 Inhalable tiotropium and container therefor ZA200604616B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303269A SE0303269L (sv) 2003-12-03 2003-12-03 Medicinsk produkt

Publications (1)

Publication Number Publication Date
ZA200604616B true ZA200604616B (en) 2009-03-25

Family

ID=29778162

Family Applications (4)

Application Number Title Priority Date Filing Date
ZA200604618A ZA200604618B (en) 2003-12-03 2004-12-02 Medical product containing tiotropium
ZA200605379A ZA200605379B (en) 2003-12-03 2004-12-02 A medical product comprising tiotropium in a moistureproof container
ZA200604616A ZA200604616B (en) 2003-12-03 2004-12-02 Inhalable tiotropium and container therefor
ZA200605380A ZA200605380B (en) 2003-12-03 2004-12-02 Pre-metered dry powder inhaler for moisture-senitive medicaments

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ZA200604618A ZA200604618B (en) 2003-12-03 2004-12-02 Medical product containing tiotropium
ZA200605379A ZA200605379B (en) 2003-12-03 2004-12-02 A medical product comprising tiotropium in a moistureproof container

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200605380A ZA200605380B (en) 2003-12-03 2004-12-02 Pre-metered dry powder inhaler for moisture-senitive medicaments

Country Status (24)

Country Link
US (4) US20050124644A1 (xx)
EP (1) EP1706099B1 (xx)
JP (1) JP2007513152A (xx)
KR (1) KR101124071B1 (xx)
CN (2) CN1913873B (xx)
AT (1) ATE507821T1 (xx)
AU (1) AU2004294886B2 (xx)
BR (1) BRPI0417155A (xx)
CA (1) CA2547781A1 (xx)
CY (1) CY1111735T1 (xx)
DE (1) DE602004032575D1 (xx)
DK (1) DK1706099T3 (xx)
ES (1) ES2362750T3 (xx)
IL (1) IL175887A (xx)
MX (1) MXPA06006238A (xx)
NZ (1) NZ547905A (xx)
PL (1) PL1706099T3 (xx)
PT (1) PT1706099E (xx)
RU (1) RU2369385C2 (xx)
SE (1) SE0303269L (xx)
SG (1) SG148206A1 (xx)
SI (1) SI1706099T1 (xx)
WO (1) WO2005053644A1 (xx)
ZA (4) ZA200604618B (xx)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US7080644B2 (en) 2000-06-28 2006-07-25 Microdose Technologies, Inc. Packaging and delivery of pharmaceuticals and drugs
CA2479751C (en) 2002-03-20 2008-06-03 Trent Poole Inhalation apparatus
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
JP2007512898A (ja) * 2003-12-03 2007-05-24 マイクロドラッグ アクチェンゲゼルシャフト 湿度に過敏な薬剤向けの予め計量されたドライパウダー吸入器
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
WO2005053647A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Medical product containing tiotropium
CA2554005C (en) 2004-02-24 2013-05-28 Microdose Technologies, Inc. Directional flow sensor inhaler
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
DK1791542T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for pharmaceutical delivery
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
ES2640282T3 (es) 2005-09-14 2017-11-02 Mannkind Corporation Método de formulación de fármacos basado en el aumento de la afinidad de superficies de micropartículas cristalinas para agentes activos
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US8371294B2 (en) 2008-02-29 2013-02-12 Microdose Therapeutx, Inc. Method and apparatus for driving a transducer of an inhalation device
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
ES2904623T3 (es) 2008-06-20 2022-04-05 Mannkind Corp Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US11116721B2 (en) 2009-02-26 2021-09-14 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
WO2010105094A1 (en) 2009-03-11 2010-09-16 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
JP5752679B2 (ja) 2009-05-21 2015-07-22 マイクロドース セラピューテクス，インコーポレイテッド 乾燥粉末吸入器のための回転カセットシステム
US8985101B2 (en) 2009-05-21 2015-03-24 Microdose Therapeutx, Inc. Method and device for clamping a blister within a dry powder inhaler
MY157166A (en) 2009-06-12 2016-05-13 Mankind Corp Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
ES2702753T3 (es) 2010-01-05 2019-03-05 Microdose Therapeutx Inc Dispositivo de inhalación
MX359281B (es) 2010-06-21 2018-09-21 Mannkind Corp Sistema y metodos para suministrar un farmaco en polvo seco.
KR101940832B1 (ko) 2011-04-01 2019-01-21 맨카인드 코포레이션 의약 카트리지용 블리스터 패키지
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
IN2014DN03093A (xx) 2011-10-24 2015-05-15 Mannkind Corp
BR112015000529B1 (pt) 2012-07-12 2022-01-11 Mannkind Corporation Inalador de pó seco
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
WO2014144895A1 (en) 2013-03-15 2014-09-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
AU2014290438B2 (en) 2013-07-18 2019-11-07 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2018071427A1 (en) 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhaler and methods of use thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5544647A (en) * 1994-11-29 1996-08-13 Iep Group, Inc. Metered dose inhalator
US5692496A (en) * 1995-08-02 1997-12-02 Innovative Devices, Llc Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
AU6014098A (en) * 1996-12-31 1998-07-31 Inhale Therapeutic Systems Aerosolized hydrophobic drug
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
US6270869B1 (en) * 1998-12-02 2001-08-07 Alusuisse Technology & Management Ltd. Cold formable laminate films
MXPA01012533A (es) * 1999-06-05 2003-10-14 Innovata Biomed Ltd Sistema de suministro.
ATE259868T1 (de) * 1999-10-11 2004-03-15 Innovata Biomed Ltd Medikamentenabgabevorrichtung mit einer feuchtigkeitsbeständigen beschichtung
SE9904706D0 (sv) * 1999-12-21 1999-12-21 Astra Ab An inhalation device
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
SE517227C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Inhalator för torrt pulver med folieskärare
JP3870159B2 (ja) * 2000-10-12 2007-01-17 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト チオトロピウムを含む新規吸入性粉剤
CZ305033B6 (cs) * 2000-10-31 2015-04-08 Boehringer Ingelheim Pharma Gmbh And Co. Kg Farmaceutický prostředek a jeho použití jako inhalační roztok
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
US20030078947A1 (en) * 2001-10-12 2003-04-24 Intel Corporation Methods for assigning unique identifiers in a distributed fault tolerant application
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
US6591832B1 (en) * 2002-02-21 2003-07-15 Saint-Gobain Calmar Inc. Dry powder dispenser
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
SE524957C2 (sv) * 2002-04-12 2004-11-02 Microdrug Ag Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament
SE525027C2 (sv) * 2002-04-12 2004-11-16 Microdrug Ag Anordning utgörande en pulverlufthyvel
SE524990C2 (sv) * 2002-04-12 2004-11-09 Microdrug Ag Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
GB0225621D0 (en) * 2002-11-02 2002-12-11 Glaxo Group Ltd Medicament carrier
CN1292748C (zh) * 2003-03-05 2007-01-03 南昌弘益科技有限公司 噻托溴铵吸入粉雾剂及其制备工艺
US20050055014A1 (en) * 2003-08-04 2005-03-10 Coppeta Jonathan R. Methods for accelerated release of material from a reservoir device
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium

Also Published As

Publication number Publication date
WO2005053644A8 (en) 2006-12-14
CN1913873A (zh) 2007-02-14
CY1111735T1 (el) 2015-10-07
RU2006122849A (ru) 2008-01-10
PL1706099T3 (pl) 2011-10-31
KR20060109933A (ko) 2006-10-23
CN1913872A (zh) 2007-02-14
MXPA06006238A (es) 2006-08-23
EP1706099A1 (en) 2006-10-04
ZA200604618B (en) 2009-03-25
SE0303269D0 (sv) 2003-12-03
ES2362750T3 (es) 2011-07-12
AU2004294886B2 (en) 2009-12-03
NZ547905A (en) 2009-06-26
IL175887A0 (en) 2006-10-05
CA2547781A1 (en) 2005-06-16
AU2004294886A1 (en) 2005-06-16
CN1913872B (zh) 2011-05-25
US20050124644A1 (en) 2005-06-09
PT1706099E (pt) 2011-06-08
SI1706099T1 (sl) 2011-07-29
BRPI0417155A (pt) 2007-03-06
JP2007513152A (ja) 2007-05-24
ZA200605380B (en) 2008-05-28
US20090041682A1 (en) 2009-02-12
ATE507821T1 (de) 2011-05-15
CN1913873B (zh) 2011-05-18
RU2369385C2 (ru) 2009-10-10
IL175887A (en) 2011-02-28
EP1706099B1 (en) 2011-05-04
DK1706099T3 (da) 2011-06-27
HK1100643A1 (en) 2007-12-07
SG148206A1 (en) 2008-12-31
DE602004032575D1 (de) 2011-06-16
ZA200605379B (en) 2008-07-30
US20060257327A1 (en) 2006-11-16
KR101124071B1 (ko) 2012-03-20
WO2005053644A1 (en) 2005-06-16
US20090192185A1 (en) 2009-07-30
SE0303269L (sv) 2005-06-04

Similar Documents

Publication Publication Date Title
ZA200604616B (en) Inhalable tiotropium and container therefor
SE0402976L (sv) Medicinsk produkt
PL1603615T3 (pl) Ulepszony układ inhalatora suchego proszku
CY1110636T1 (el) Προ-δοσιμετρημενος εισπνευστηρας ξηρης σκονης για φαρμακα ευαισθητα στην υγρασια
WO2004112702A3 (en) Low dose pharmaceutical powders for inhalation
CY1110625T1 (el) Μεθοδος για την χορηγηση τιοτροπιου
MX371521B (es) Sistema de inhalacion de polvo seco.
WO2006008517A3 (en) Use of dry powder compositions for pulmonary delivery
WO2005041921A3 (en) Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor
ZA200700443B (en) Enhanced medical product
JP2004533438A5 (xx)